Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
NCT01693302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2012-09-26
Summary
Blood glucose levels in patients with type 1 diabetes tend to peak after eating a meal due to the delayed action of insulin when compared to carbohydrate absorption from food. It is the hypothesis of the investigator that administering the insulin for a meal 20 minutes before the meal will result in lower blood glucose peaks compared to administration of insulin immediately before or 20 minutes after starting to eat.
All subjects will eat the same meal on three different occasions. Insulin will be administered at one of the three times at each visit.
Conditions
Interventions
- OTHER
-
Insulin
The timing of insulin delivery varies with each study visit. The dose is given based on carbohydrate content and blood glucose level. The insulin is given either 20 minutes before the meal, immediately before the meal, or 20 minutes after the meal.
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Peter Chase, MD · University of Colorado, Denver
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 12 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2009-05-31
- Completion
- 2009-05-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
NCT00553488 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls
NCT00927524 ·Status: COMPLETED ·Phase: NA
-
Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia
NCT00475345 ·Status: COMPLETED ·Phase: NA
-
Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia
NCT03179280 ·Status: COMPLETED ·Phase: NA
-
Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM
NCT02204839 ·Status: COMPLETED ·Phase: NA
-
Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
NCT00340613 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
NCT00509925 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
NCT04157738 ·Status: COMPLETED ·Phase: PHASE4
-
Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
NCT03490942 ·Status: TERMINATED ·Phase: PHASE2
-
Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes
NCT02416765 ·Status: COMPLETED ·Phase: PHASE2
-
Pramlintide in Adolescents With Type 1 Diabetes
NCT00842075 ·Status: COMPLETED ·Phase: NA
-
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
NCT04614168 ·Status: COMPLETED ·Phase: NA
-
Impact of Hybrid Closed-Loop Systems on Sleep and Psychosocial Outcomes in Youth With T1D and Their Parents
NCT04431947 ·Status: COMPLETED
-
Time Limited Eating in Type 1 Diabetes
NCT05031429 ·Status: COMPLETED ·Phase: NA
-
Glycaemic Load and Pre-meal Insulin Doses in Type 1 Diabetes Patients
NCT01978704 ·Status: COMPLETED ·Phase: NA
-
Best Timing of Insulin Bolus Before Meals of Different Contents
NCT01406496 ·Status: UNKNOWN ·Phase: NA
-
Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation
NCT02626936 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
NCT05762107 ·Status: RECRUITING ·Phase: PHASE2
-
Need-driven Treatment of the Patients With Type 1 Diabetes
NCT07128992 ·Status: NOT_YET_RECRUITING
-
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
NCT01769404 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
NCT00419562 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Mealtime Bolus Insulin Behavior
NCT03368807 ·Status: COMPLETED
-
Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
NCT04783376 ·Status: COMPLETED ·Phase: PHASE4
-
Extended Bolus for Meals in a Closed-loop System
NCT05454891 ·Status: COMPLETED ·Phase: NA
-
Measuring and Predicting Glycemic Response to Food in Patients With Type 1 Diabetes
NCT02919839 ·Status: UNKNOWN